John P. Bingham

651 total citations
22 papers, 531 citations indexed

About

John P. Bingham is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, John P. Bingham has authored 22 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in John P. Bingham's work include Cancer therapeutics and mechanisms (6 papers), DNA and Nucleic Acid Chemistry (6 papers) and Synthesis and Biological Evaluation (5 papers). John P. Bingham is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), DNA and Nucleic Acid Chemistry (6 papers) and Synthesis and Biological Evaluation (5 papers). John P. Bingham collaborates with scholars based in United Kingdom, Italy and United States. John P. Bingham's co-authors include John A. Hartley, Robert L. Souhami, J.A. Hartley, Romeo Romagnoli, Pier Giovanni Baraldi, Miguel Á. Gallo, Jane L. Holley, Gerald M. Cohen, Richard T. Wheelhouse and Antonio Espinosa and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Analytical Biochemistry.

In The Last Decade

John P. Bingham

22 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Bingham United Kingdom 14 281 218 176 40 35 22 531
Guy Fournet France 20 279 1.0× 411 1.9× 150 0.9× 48 1.2× 19 0.5× 47 844
Juiwanna Kushner United States 22 697 2.5× 389 1.8× 140 0.8× 14 0.3× 17 0.5× 31 1.1k
Gene K. Yee United States 8 383 1.4× 76 0.3× 171 1.0× 44 1.1× 23 0.7× 12 706
Mary K. Wolpert-DeFilippes United States 10 268 1.0× 126 0.6× 215 1.2× 37 0.9× 44 1.3× 13 507
Claudia Caserini Italy 13 570 2.0× 179 0.8× 578 3.3× 19 0.5× 79 2.3× 15 919
Charles Watson Moore United States 8 205 0.7× 166 0.8× 154 0.9× 20 0.5× 48 1.4× 9 450
Ridong Li China 15 387 1.4× 273 1.3× 98 0.6× 16 0.4× 27 0.8× 42 666
Fortuna Haviv United States 13 331 1.2× 236 1.1× 72 0.4× 30 0.8× 9 0.3× 24 620
Akanksha Arvind India 8 234 0.8× 77 0.4× 187 1.1× 16 0.4× 21 0.6× 8 534
Andrew M. Creighton United Kingdom 12 507 1.8× 100 0.5× 230 1.3× 54 1.4× 31 0.9× 15 683

Countries citing papers authored by John P. Bingham

Since Specialization
Citations

This map shows the geographic impact of John P. Bingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Bingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Bingham more than expected).

Fields of papers citing papers by John P. Bingham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Bingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Bingham. The network helps show where John P. Bingham may publish in the future.

Co-authorship network of co-authors of John P. Bingham

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Bingham. A scholar is included among the top collaborators of John P. Bingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Bingham. John P. Bingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tiberghien, Arnaud, Balakumar Vijayakrishnan, John P. Bingham, et al.. (2022). Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity. Molecular Cancer Therapeutics. 22(2). 254–263. 3 indexed citations
2.
Hartley, John A., Michael Flynn, John P. Bingham, et al.. (2018). Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine. Scientific Reports. 8(1). 10479–10479. 85 indexed citations
3.
Satam, Vijay, Balaji Babu, Pravin Patil, et al.. (2015). AzaHx, a novel fluorescent, DNA minor groove and G·C recognition element: Synthesis and DNA binding properties of a p-anisyl-4-aza-benzimidazole-pyrrole-imidazole (azaHx-PI) polyamide. Bioorganic & Medicinal Chemistry Letters. 25(17). 3681–3685. 10 indexed citations
4.
Uboldi, Sarah, Roberta Frapolli, Simonetta Andrea Licandro, et al.. (2015). Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin. British Journal of Cancer. 113(12). 1687–1693. 37 indexed citations
5.
Satam, Vijay, Pravin Patil, Balaji Babu, et al.. (2013). Hx-amides: DNA sequence recognition by the fluorescent Hx (p-anisylbenzimidazole)•pyrrole and Hx•imidazole pairings. Bioorganic & Medicinal Chemistry Letters. 23(6). 1699–1702. 5 indexed citations
6.
Amin, Jahangir, Irina Chuckowree, Graham J. Tizzard, et al.. (2013). Targeting Epidermal Growth Factor Receptor with Ferrocene-Based Kinase Inhibitors. Organometallics. 32(2). 509–513. 18 indexed citations
7.
Abdallah, Qasem, Roger M. Phillips, Fredrik Johansson, et al.. (2012). Minor structural modifications to alchemix influence mechanism of action and pharmacological activity. Biochemical Pharmacology. 83(11). 1514–1522. 4 indexed citations
8.
Spanswick, Victoria J., Helen L. Lowe, Claire Newton, et al.. (2012). Evidence for different mechanisms of ‘unhooking’ for melphalan and cisplatin-induced DNA interstrand cross-links in vitroand in clinical acquired resistant tumour samples. BMC Cancer. 12(1). 436–436. 24 indexed citations
9.
Spanswick, Victoria J., John P. Bingham, Konstantinos Kiakos, et al.. (2012). Abstract 1766: Persistence of drug-induced DNA interstrand cross-links distinguishes bendamustine from conventional DNA cross-linking agents. Cancer Research. 72(8_Supplement). 1766–1766. 2 indexed citations
10.
Spencer, John, Jahangir Amin, J.E. McGeehan, et al.. (2011). Size Does Matter. Sterically Demanding Metallocene-Substituted 3-Methylidene-Oxindoles Exhibit Poor Kinase Inhibitory Action. Organometallics. 30(11). 3177–3181. 17 indexed citations
11.
Bingham, John P., et al.. (2009). Azinomycin bisepoxides containing rigid aromatic linkers: synthesis, cytotoxicity and DNA interstrand cross-linking activity. Tetrahedron Letters. 50(26). 3648–3650. 5 indexed citations
12.
Parker, Laurie L., et al.. (2005). Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. Bioorganic & Medicinal Chemistry. 13(7). 2389–2395. 16 indexed citations
13.
Baraldi, Pier Giovanni, Italo Beria, Paolo Cozzi, et al.. (2004). Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies. Bioorganic & Medicinal Chemistry. 12(14). 3911–3921. 34 indexed citations
14.
Urbaniak, Michael D., John P. Bingham, Lloyd R. Kèlland, et al.. (2003). Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore. Bioorganic & Medicinal Chemistry Letters. 13(12). 2025–2027. 4 indexed citations
15.
Grimaldi, Keith, John P. Bingham, & John A. Hartley. (2003). PCR-Based Assays for Strand-Specific Measurement of DNA Damage and Repair I: Strand-Specific Quantitative PCR. Humana Press eBooks. 113. 227–240. 2 indexed citations
16.
Baraldi, Pier Giovanni, Romeo Romagnoli, Maria Giovanna Pavani, et al.. (2002). Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity. Bioorganic & Medicinal Chemistry. 10(5). 1611–1618. 17 indexed citations
17.
Baraldi, Pier Giovanni, Romeo Romagnoli, María José Pineda de las Infantas y Villatoro, et al.. (2002). Design, Synthesis, and Biological Activity of Hybrid Compounds between Uramustine and DNA Minor Groove Binder Distamycin A. Journal of Medicinal Chemistry. 45(17). 3630–3638. 55 indexed citations
18.
Gee, Kyle R., et al.. (2000). New ratiometric fluorescent calcium indicators with moderately attenuated binding affinities. Bioorganic & Medicinal Chemistry Letters. 10(14). 1515–1518. 23 indexed citations
19.
Grimaldi, Keith, John P. Bingham, R L Souhami, & John A. Hartley. (1994). DNA Damage by Anticancer Agents and Its Repair: Mapping in Cells at the Subgene Level with Quantitative Polymerase Chain Reaction. Analytical Biochemistry. 222(1). 236–242. 28 indexed citations
20.
Hartley, J.A., John P. Bingham, & Robert L. Souhami. (1992). DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells. Nucleic Acids Research. 20(12). 3175–3178. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026